| Issue Date | Title | Author(s) |
| Dec-2022 | Comparison of hepatitis B virus reactivation in hepatocellular carcinoma patients who received tyrosine kinase inhibitor alone or together with programmed cell death protein-1 inhibitors | Lei, Jin; Yan, Tao; Zhang, Linzhi; Chen, Bowen; Cheng, Jiamin; Gao, Xiaoqiang; Liu, Zherui; Li, Yinyin; Zuo, Shi; Lu, Yinying |
| 1-Jun-2023 | Efficacy and safety in unresectable hepatocellular carcinoma using atezolizumab plus bevacizumab in later-line: A retrospective analysis of real-world evidence. | Cheng, Jiamin; Chen, Bowen; Zhang, Xinfeng; Su, Guodong; Peng, Caiyun; Zhou, Lin; Lei, Jin; Li, Yinyin; Lu, Yinying |
| 1-Jun-2023 | Efficacy and safety in unresectable hepatocellular carcinoma with VP4 tumor embolus using sinilimab plus bevacizumab: A retrospective analysis of real-world evidence | Cheng, Jiamin; Chen, Bowen; Zhang, Xinfeng; Su, Guodong; Peng, Caiyun; Lei, Jin; Yu, Lingxiang; Li, Yinyin; Lu, Yinying |
| Aug-2021 | Efficacy and Safety of Niraparib as Maintenance Treatment in Patients With Extensive-Stage SCLC After First-Line Chemotherapy: A Randomized, Double-Blind, Phase 3 Study | Ai, Xinghao; Pan, Yueyin; Shi, Jianhua; Yang, Nong; Liu, Chunling; Zhou, Jianying; Zhang, Xiaodong; Dong, Xiaorong; He, Jianxing; Li, Xiaoling; Chen, Gongyan; Li, Xingya; Zhang, Helong; Liao, Wangjun; Zhang, Yiping; Ma, Zhiyong; Jiang, Liyan; Cui, Jiuwei; Hu, Chunhong; Wang, Wei; Huang, Cheng; Zhao, Jun; Ding, Cuimin; Hu, Xiaohua; Wang, Kai; Gao, Beili; Song, Yong; Liu, Xiaoqing; Xiong, Jianping; Liu, Anwen; Li, Junling; Liu, Zhe; Li, Yinyin; Wang, Mengzhao; Zhang, Biao; Zhang, Dan; Lu, Shun |
| 2022 | Efficacy and Safety of TKI Plus PD-1 Inhibitors in Elderly uHCC Patients: A Retrospective Study | Chen, Bowen; Lei, Jin; Zhao, Haitao; Dong, Jinghui; Zeng, Zhen; Li, Yinyin; Yu, Lingxiang; Zhou, Lin; Jia, Aiying; Lu, Yinying; Cheng, Jiamin |
| 2023 | Efficacy and Safety of Tyrosine Kinase Inhibitors Alone or Combination with Programmed Death-1 Inhibitors in Treating of Hepatitis C-Related Hepatocellular Carcinoma | Lei, Jin; Yang, Sibo; Chen, Bowen; Zhang, Linzhi; Yan, Tao; Yang, Gangqi; Chen, Yue; Li, Yinyin; Lu, Yinying; Zuo, Shi |
| 2021 | The hierarchical folding dynamics of topologically associating domains are closely related to transcriptional abnormalities in cancers | Du, Guifang; Li, Hao; Ding, Yang; Jiang, Shuai; Hong, Hao; Gan, Jingbo; Wang, Longteng; Yang, Yuanping; Li, Yinyin; Huang, Xin; Sun, Yu; Tao, Huan; Li, Yaru; Xu, Xiang; Zheng, Yang; Wang, Junting; Bai, Xuemei; Xu, Kang; Li, Yaoshen; Jiang, Qi; Li, Cheng; Chen, Hebing; Bo, Xiaochen |
| 8-Mar-2022 | Intestinal Candida albicans Promotes Hepatocarcinogenesis by Up-Regulating NLRP6 | Liu, Zherui; Li, Yinyin; Li, Chen; Lei, Guanglin; Zhou, Lin; Chen, Xiangling; Jia, Xiaodong; Lu, Yinying |
| Feb-2023 | Optimization and Mechanism of Cadmium Removal Using Biochar Obtained from Wetland Emergent Plant Zizania caduciflora | Wang, Xiaoshu; Wang, Yan; Luo, Yimin; Wang, Yangyang; Xu, Nan; Zhu, Jia; Li, Yinyin; Wang, Longquan; Wang, Jinsheng; Huang, Xuquan; Wang, Lei |
| Jul-2022 | Risk factors for hepatic encephalopathy in hepatocellular carcinoma after sorafenib or lenvatinib treatment: a real-world study | Chen, Bowen; Zhang, Linzhi; Cheng, Jiamin; Yang, Xu; Lei, Jin; Wu, Tong; Yan, Tao; Li, Yinyin; Lu, Yinying |
| 9-Dec-2022 | TKI or TKI combined with PD-1 inhibitors as second-line treatment for HCC patients after sorafenib failure | Lei, Jin; Chen, Bowen; Song, Meiru; Zhang, Linzhi; Zhang, Xinfeng; Gao, Xiaoqiang; Li, Yinyin; Lu, Yinying; Zuo, Shi |
